Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification

Biochemical Journal

Volumn 454, Issue 1, 2013, Pages 147-156

  Dolgova, Nataliya V ^a   Nokhrin, Sergiy ^a   Yu, Corey H ^a   George, Graham N ^a   Dmitriev, Oleg Y ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Atpase; Cisplatin; Cu(I) transport; Drug resistance; Metal transport; Wilson disease protein (ATP7B)

Indexed keywords

ATOX1 PROTEIN; CARBOPLATIN; CHAPERONE; CISPLATIN; COPPER; CYSTEINE; METHYL CPG BINDING PROTEIN 2; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; DRUG DETOXIFICATION; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; X RAY ABSORPTION SPECTROSCOPY;

ADENOSINE TRIPHOSPHATASES; BINDING SITES; CATION TRANSPORT PROTEINS; CISPLATIN; COPPER; HUMANS; METALLOCHAPERONES; REPETITIVE SEQUENCES, AMINO ACID; X-RAY ABSORPTION SPECTROSCOPY;

EID: 84880868563     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121656     Document Type: Article

References (51)

1. Jung, Y. and Lippard, S. J. (2007) Direct cellular responses to platinum-induced DNA damage. Chem. Rev. 107, 1387-1407.
2. Wang, X. (2010) Fresh platinum complexes with promising antitumor activity. Anti-Cancer Agents Med. Chem. 10, 396-411.
3. Jamieson, E. R. and Lippard, S. J. (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99, 2467-2498.
4. Mandic, A., Hansson, J., Linder, S. and Shoshan, M. C. (2003) Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J. Biol. Chem. 278, 9100-9106.
5. Siddik, Z. H. (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279.
6. Dmitriev, O. Y. (2011) Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B. Biochem. Cell Biol. 89, 138-147.
7. Gupta, A. and Lutsenko, S. (2009) Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med. Chem. 1, 1125-1142.
8. Howell, S. B., Safaei, R., Larson, C. A. and Sailor, M. J. (2010) Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol. Pharmacol. 77, 887-894.
9. Ishida, S., Lee, J., Thiele, D. J. and Herskowitz, I. (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. U.S.A. 99, 14298-14302.
10. Blair, B. G., Larson, C. A., Safaei, R. and Howell, S. B. (2009) Copper transporter 2 regulates the cellular accumulation and cytotoxicity of cisplatin and carboplatin. Clin. Cancer Res. 15, 4312-4321.
11. Arnesano, F., Banci, L., Bertini, I., Felli, I. C., Losacco, M. and Natile, G. (2011) Probing the interaction of cisplatin with the human copper chaperone Atox1 by solution and in-cell NMR spectroscopy. J. Am. Chem. Soc. 133, 18361-18369.
12. Boal, A. K. and Rosenzweig, A. C. (2009) Crystal structures of cisplatin bound to a human copper chaperone. J. Am. Chem. Soc. 131, 14196-14197.
13. Palm, M. E., Weise, C. F., Lundin, C., Wingsle, G., Nygren, Y., Bjorn, E., Naredi, P., Wolf-Watz, M. and Wittung-Stafshede, P. (2011) Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro. Proc. Natl. Acad. Sci. U.S.A. 108, 6951-6956.
14. Hua, H., Gunther, V., Georgiev, O. and Schaffner, W. (2011) Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila . BioMetals 24, 445-453.
15. Safaei, R., Maktabi, M. H., Blair, B. G., Larson, C. A. and Howell, S. B. (2009) Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. J. Inorg. Biochem. 103, 333-341.
16. Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z. S., Terada, K., Furukawa, T., Yang, X. L., Gao, H., Miura, N., Sugiyama, T. and Akiyama, S. (2000) Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 60, 1312-1316.
17. Samimi, G., Safaei, R., Katano, K., Holzer, A. K., Rochdi, M., Tomioka, M., Goodman, M. and Howell, S. B. (2004) Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin. Cancer Res. 10, 4661-4669.
18. Lutsenko, S., Barnes, N. L., Bartee, M. Y. and Dmitriev, O. Y. (2007) Function and regulation of human copper-transporting ATPases. Physiol. Rev. 87, 1011-1046.
19. DiDonato, M., Narindrasorasak, S., Forbes, J. R., Cox, D. W. and Sarkar, B. (1997) Expression, purification, and metal binding properties of the N-terminal domain from the wilson disease putative copper-transporting ATPase (ATP7B). J. Biol. Chem. 272, 33279-33282.
20. Lutsenko, S., Petrukhin, K., Cooper, M. J., Gilliam, C. T. and Kaplan, J. H. (1997) N-terminal domains of human copper-transporting adenosine triphosphatases (the Wilson's and Menkes disease proteins) bind copper selectively in vivo and in vitro with stoichiometry of one copper per metal-binding repeat. J. Biol. Chem. 272, 18939-18944.
21. Yatsunyk, L. A. and Rosenzweig, A. C. (2007) Cu(I) binding and transfer by the N terminus of the Wilson disease protein. J. Biol. Chem. 282, 8622-8631.
22. Gonzalez-Guerrero, M. and Arguello, J. M. (2008) Mechanism of Cu+ -transporting ATPases: soluble Cu+ chaperones directly transfer Cu+ to transmembrane transport sites. Proc. Natl. Acad. Sci. U.S.A. 105, 5992-5997.
23. Cater, M. A., Forbes, J., La Fontaine, S., Cox, D. and Mercer, J. F. (2004) Intracellular trafficking of the human Wilson protein: The role of the six N-terminal metal-binding sites. Biochem. J. 380, 805-813.
24. Huster, D. and Lutsenko, S. (2003) The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein. J. Biol. Chem. 278, 32212-32218.
25. Safaei, R., Otani, S., Larson, B. J., Rasmussen, M. L. and Howell, S. B. (2008) Transport of cisplatin by the copper efflux transporter ATP7B. Mol. Pharmacol. 73, 461-468.
26. Dolgova, N. V., Olson, D., Lutsenko, S. and Dmitriev, O. Y. (2009) The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin. Biochem. J. 419, 51-56.
27. Kasherman, Y., Sturup, S. and Gibson, D. (2009) Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts. J. Biol. Inorg. Chem. 14, 387-399.
28. Ishikawa, T. and Ali-Osman, F. (1993) Glutathione-Associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J. Biol. Chem. 268, 20116-20125.
29. Lempers, E. L. M. and Reedijk, J. (1991) Interactions of platinum amine compounds with sulfur-containing biomolecules and DNA fragments. Adv. Inorg. Chem. 37, 175-217.
30. Yokomizo, A., Ono, M., Nanri, H., Makino, Y., Ohga, T., Wada, M., Okamoto, T., Yodoi, J., Kuwano, M. and Kohno, K. (1995) Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res. 55, 4293-4296.
31. Morgan, C. T., Tsivkovskii, R., Kosinsky, Y. A., Efremov, R. G. and Lutsenko, S. (2004) The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: Analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F. J. Biol. Chem. 279, 36363-36371.
32. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J. and Bax, A. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
33. Guntert, P. (2004) Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278, 353-378.
34. Bhattacharya, A., Tejero, R. and Montelione, G. T. (2007) Evaluating protein structures determined by structural genomics consortia. Proteins 66, 778-795.
35. Walker, J. M., Huster, D., Ralle, M., Morgan, C. T., Blackburn, N. J. and Lutsenko, S. (2004) The N-terminal metal-binding site 2 of the Wilson's disease protein plays a key role in the transfer of copper from Atox1. J. Biol. Chem. 279, 15376-15384.
36. Banci, L., Bertini, I., Del Conte, R., D'Onofrio, M. and Rosato, A. (2004) Solution structure and backbone dynamics of the Cu(I) and apo forms of the second metal-binding domain of the Menkes protein ATP7A. Biochemistry 43, 3396-3403.
37. Safaei, R., Adams, P. L., Maktabi, M. H., Mathews, R. A. and Howell, S. B. (2012) The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin. J. Inorg. Biochem. 110, 8-17.
38. Pattanaik, A., Bachowski, G., Laib, J., Lemkuil, D., Shaw, III C. F., Petering, D. H., Hitchcock, A. and Saryan, L. (1992) Properties of the reaction of cis-dichlorodiammineplatinum(II) with metallothionein. J. Biol. Chem. 267, 16121-16128.
39. Beck, M., Schmidt, A., Malmstroem, J., Claassen, M., Ori, A., Szymborska, A., Herzog, F., Rinner, O., Ellenberg, J. and Aebersold, R. (2011) The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549.
40. Knipp, M., Karotki, A. V., Chesnov, S., Natile, G., Sadler, P. J., Brabec, V. and Vasak, M. (2007) Reaction of Zn7metallothionein with cis- And trans-[Pt(N-donor)2Cl2] anticancer complexes: Trans-PtII complexes retain their N-donor ligands. J. Med. Chem. 50, 4075-4086.
41. Reedijk, J. (1999) Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell? Chem. Rev. 99, 2499-2510.
42. Obata, M., Harada, M., Ohi, H., Hirohara, S., Gottchaldt, M. and Yano, S. (2009) Extended X-ray absorption fine structure study on reaction of anti-tumor platinum complexes with reduced glutathione. Chem. Pharm. Bull. 57, 1107-1109.
43. Bombard, S., Gariboldi, M. B., Monti, E., Gabano, E., Gaviglio, L., Ravera, M. and Osella, D. (2010) Biological activity of enantiomeric complexes [PtCl2L2] (L2 is aromatic bisphosphanes and aromatic diamines). J. Biol. Inorg. Chem. 15, 841-850.
44. Mugge, C., Rothenburger, C., Beyer, A., Gorls, H., Gabbiani, C., Casini, A., Michelucci, E., Landini, I., Nobili, S., Mini, E. et al. (2011) Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. Dalton Trans. 40, 2006-2016.
45. Wang, D. and Lippard, S. J. (2005) Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discovery 4, 307-320.
46. Mangala, L. S., Zuzel, V., Schmandt, R., LeShane, E. S., Halder, J. B., Armaiz-Pena, G. N., Spannuth, W. A., Tanaka, T., Shahzad, M. M., Lin, Y. G. et al. (2009) Therapeutic targeting of ATP7B in ovarian carcinoma. Clin. Cancer Res. 15, 3770-3780.
47. Yoshizawa, K., Nozaki, S., Kitahara, H., Ohara, T., Kato, K., Kawashiri, S. and Yamamoto, E. (2007) Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncol. Rep. 18, 987-991.
48. Banci, L., Bertini, I., Cantini, F., Massagni, C., Migliardi, M. and Rosato, A. (2009) An NMR study of the interaction of the N-terminal cytoplasmic tail of the Wilson disease protein with copper(I)-HAH1. J. Biol. Chem. 284, 9354-9360.
49. Singleton, W. C., McInnes, K. T., Cater, M. A., Winnall, W. R., McKirdy, R., Yu, Y., Taylor, P. E., Ke, B. X., Richardson, D. R., Mercer, J. F. and La Fontaine, S. (2010) Role of glutaredoxin1 and glutathione in regulating the activity of the copper-transporting P-type ATPases, ATP7A and ATP7B. J. Biol. Chem. 285, 27111-27121.
50. Peleg-Shulman, T., Najajreh, Y. and Gibson, D. (2002) Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles. J. Inorg. Biochem. 91, 306-311.
51. Itoh, S., Kim, H. W., Nakagawa, O., Ozumi, K., Lessner, S. M., Aoki, H., Akram, K., McKinney, R. D., Ushio-Fukai, M. and Fukai, T. (2008) Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J. Biol. Chem. 283, 9157-9167.